| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | 0.041 | 0.7 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.054 | 0.8 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |